End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 CNY | 0.00% | +6.11% | -5.79% |
Business Summary
China accounts for 86.3% of net sales.
Number of employees: 6,214
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other
42.9
%
| 3,745 | 42.5 % | 3,539 | 42.9 % | -5.52% |
Preparation
41.3
%
| 3,593 | 40.8 % | 3,408 | 41.3 % | -5.15% |
Raw Material
15.7
%
| 1,470 | 16.7 % | 1,296 | 15.7 % | -11.84% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 8,809 | 100.0 % | 8,243 | 100.0 % | -6.42% |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kai Zhou
CEO | Chief Executive Officer | 60 | 05-04-30 |
Guo Dong Wang
BRD | Director/Board Member | 82 | 18-07-17 |
Zhao Chun Tan
BRD | Director/Board Member | 59 | 21-11-16 |
Zhi Hua Huang
BRD | Director/Board Member | 56 | 21-11-16 |
Cheng Ren Huang
BRD | Director/Board Member | 60 | 18-07-17 |
You Guang Shang
BRD | Director/Board Member | 58 | 20-10-28 |
Demin Han
BRD | Director/Board Member | 73 | 18-07-17 |
Hui Yao
BRD | Director/Board Member | 60 | 18-07-17 |
Bai Dan Zhan
CHM | Chairman | 50 | 18-12-26 |
Jian Min Guo
CHM | Chairman | 53 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,429,103,265 | 596,135,801 ( 41.71 %) | 40,765,000 ( 2.852 %) | 41.71 % |
Company contact information
Northeast Pharmaceutical Group Co., Ltd.
Shenyang Economics & Tech Dev Zone 8, Kunming Lake Street
110027, Shenyang
+86 24 2580 6963
http://www.nepharm.com.cnSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-5.79% | 998M | |
+33.43% | 700B | |
+27.59% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.21% | 236B | |
+6.66% | 202B | |
-9.41% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- 000597 Stock
- Company Northeast Pharmaceutical Group Co., Ltd.